![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1528.png)
Systemic treatment
•
Indication – extrapolate from histology (breast adenoCa)
–
N+, LVSI+ - in breast Ca, would offer systemic treatment
•
What systemic treatment?
–
Consider therapeutic indices AND economic cost
–
ER positive - give tamoxifen (benefit U/K, toxicity low,
cost low)
–
HER-2 positive – do not give Herceptin (benefit U/K,
toxicity high, cost very high)
–
Chemo - ??? (benefit U/K, toxicity high, cost high)